As of 10:35am ET
| +0.0214 / +3.90%|
The 1 analysts offering 12-month price forecasts for MabVax Therapeutics Holdings Inc have a median target of 480.00, with a high estimate of 480.00 and a low estimate of 480.00. The median estimate represents a +84,110.53% increase from the last price of 0.57.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.